Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIROGACESTAT vs NIRSEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIROGACESTAT vs NIRSEVIMAB: Safety Overview

Metric NIROGACESTAT NIRSEVIMAB
Total FAERS Reports 497 247
Deaths Reported 7 5
Death Rate 1.4% 2.0%
Hospitalizations 54 149
Average Patient Age 45.2 yrs 0.3 yrs
% Female Patients 69.6% 42.3%
Manufacturer SpringWorks Therapeutics, Inc. Sanofi Pasteur Inc.
Route ORAL INTRAMUSCULAR